DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to ...
MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.
Rarer diabetes patients in Singapore can now receive up to 80% government subsidies for continuous glucose monitoring (CGM) ...
IEEE Spectrum on MSN
Why the most accurate glucose monitors are failing some users
In late November Abbott—one of Dexcom’s main competitors— recalled some of its CGMs due to inaccurate low glucose readings. The recall affects approximately 3 million sensors and was caused by an ...
Zacks Investment Research on MSN
Here's why you should hold DexCom stock in your portfolio for now
DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the continuous glucose ...
Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...
The model, 34, and the comedian, 37, who are parents to daughter Elsie, two, became engaged when he popped the question in ...
One of the main threads running through our most-read stories of 2025—as much as ever in the medtech industry writ large—is ...
Zacks.com on MSN
4 Medical Device Stocks to Buy for Healthy Returns in 2026
Detailed price information for Idexx Laboratories (IDXX-Q) from The Globe and Mail including charting and trades.
GlucoModicum today unveiled Sofio, which it labels the world's first needle-free glucose monitor based on ...
Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance.
Continuous glucose monitoring may have a role in identifying and preventing diabetes among healthy adults, but more studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback